{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T10:33:58Z","timestamp":1722767638921},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1097\/md.0000000000005555","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T15:19:07Z","timestamp":1481210347000},"page":"e5555","source":"Crossref","is-referenced-by-count":4,"title":["Sofosbuvir and ribavirin in acute hepatitis C\u2013infected patient with decompensated cirrhosis"],"prefix":"10.1097","volume":"95","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-56-20210226","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing and treating adults infected with hepatitis C virus.","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"R2-56-20210226","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-56-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"R4-56-20210226","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27922","article-title":"Safety and efficacy of simeprevir\/sofosbuvir in hepatitis C-infected patients with compensated and decompensated cirrhosis","volume":"62","author":"Saxena","year":"2015","journal-title":"Hepatology"},{"key":"R5-56-20210226","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14787210.2016.1147952","article-title":"Optimum combination therapy regimens for HIV\/HCV infection","volume":"14","author":"Rey","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R6-56-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/liv.12715","article-title":"Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C","volume":"35","author":"Welch","year":"2015","journal-title":"Liver Int"},{"key":"R7-56-20210226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"R8-56-20210226","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"Hofer","year":"2003","journal-title":"Hepatology"},{"key":"R9-56-20210226","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial","volume":"310","author":"Osinusi","year":"2013","journal-title":"JAMA"},{"key":"R10-56-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.27366","article-title":"Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus","volume":"61","author":"Yoshida","year":"2015","journal-title":"Hepatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:39:05Z","timestamp":1620959945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201612060-00056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":10,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005555","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}